Journal of medical case reports · 2025
Cushing's syndrome in a young woman due to prolonged betamethasone nasal drop use: a case report.
СтатьяКлинический случайНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Shamohammadi Mohammadsadra, Eskandari Delaram, Ziaee Amir, Samadanifard Seyed Hossein, Chehrehgosha Haleh, Ghanooni Amir Hossein
Аннотация
BACKGROUND: Cushing's syndrome is an uncommon but serious condition caused by long-term exposure to elevated cortisol levels, which is usually iatrogenic in origin. Although systemic corticosteroids are the most frequent agents, the association of intranasal corticosteroids with this condition is remarkably rare.
CASE PRESENTATION: This report is about a 21-year-old Iranian woman using betamethasone nasal drops for nasal obstruction. The patient presented with weight gain, Amenorrhea, mood disturbances, red purplish striae, and mild hirsutism. Hormonal assessments revealed suppression of the hypothalamic-pituitary-adrenal axis.
CONCLUSION: This case demonstrates the underappreciated systemic effects of intranasal betamethasone to induce Cushing's syndrome. It serves as a pivotal reminder of the need for vigilance in prescribing practices and reinforces the importance of early diagnosis to ensure favorable patient outcomes.
CASE PRESENTATION: This report is about a 21-year-old Iranian woman using betamethasone nasal drops for nasal obstruction. The patient presented with weight gain, Amenorrhea, mood disturbances, red purplish striae, and mild hirsutism. Hormonal assessments revealed suppression of the hypothalamic-pituitary-adrenal axis.
CONCLUSION: This case demonstrates the underappreciated systemic effects of intranasal betamethasone to induce Cushing's syndrome. It serves as a pivotal reminder of the need for vigilance in prescribing practices and reinforces the importance of early diagnosis to ensure favorable patient outcomes.